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Background: Extraction of DNA from formalin-fixed, paraffin-embedded (FFPE) tissue is a critical step in molecular
oncologic testing. As molecular oncology testing becomes more important for prognostic and therapeutic decision
making and tissue specimens become smaller due to earlier detection of suspicious lesions and the use of fine
needle aspiration methods for tissue collection, it becomes more challenging for the typical molecular pathology
laboratory to obtain reliable test results. We developed a DNA extraction method to obtain sufficient quantity and
high quality genomic DNA from limited FFPE tissue for molecular oncology testing using a combination of H&E
stained slides, a matrix capture method and the Qiagen DNA column.
Methods: Three DNA extraction methods were compared: our standard procedure of manually scraping tissue
from unstained slides followed by DNA extraction using the QIAamp FFPE column (Qiagen, Valencia, CA), a glue
capture method (Pinpoint Solution, Zymo Research Corp, Inc) on H&E stained slides followed by DNA extraction
using either the QIAamp column or the column included with the Pinpoint kit (Zymo Research). The DNA extraction
protocol was optimized. Statistical analysis was performed using the paired two-sample student’s t-test.
Results: The combination of the matrix capture method with the QIAamp column gave an equivalent amount of DNA
as our standard extraction method using the unstained slides and a 4.6-fold higher DNA yield than using the Zymo
column included in the Pinpoint Slide Solution kit. Several molecular tests were performed and DNA purified using the
new method gave the same results as for the previous methods.
Conclusions: Using H&E stained slides allows visual confirmation of tumor cells during microdissection. The Pinpoint
solution made removal of specific tissue from the slides easier and reduced the risk of contamination and tissue loss.
This DNA extraction method is simple, cost-effective, and blends with our current workflow requiring no additional
equipment.
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Isolating genomic DNA (gDNA) from formalin-fixed,
paraffin-embedded (FFPE) tissue is a critical step in mo-
lecular oncologic testing [1-6]. In most molecular diag-
nostic laboratories, this is done by cutting one or two
hematoxylin and eosin (H&E) stained slides and 5-10
unstained sections, 6-10 microns in thickness, from
FFPE tissue blocks. The H&E slide is reviewed by a* Correspondence: deqin-ma@uiowa.edu
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unless otherwise stated.pathologist; the area of interest is circled; and the slide is
used to guide macro- or microdissection of the tissue
from the unstained sections for tumor enrichment
[7-10]. When resection specimens with large areas of
tumor are available, this technique is facile. Increasingly
though, molecular analysis from small biopsies or fine
needle aspirates (FNA) is requested due to improved tol-
erance by patients and decreased invasiveness of the
procedure. Since fewer tumor cells are available in these
specimens, it can be very challenging to obtain enough
DNA for testing, particularly in testing for the spectrum
of epidermal growth factor [11] exons 18-21 mutationstd. This is an Open Access article distributed under the terms of the Creative
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Figure 1 Microdissection of H and E stained slides using matrix
capture method. Unstained slides (6 microns in thickness) were
deparaffinized and H&E stained as described in Methods section. A
and B: Pre- and post- removal of a 1 mm2 nest of adenocarcinoma
cells from the pinpoint-treated section (4x); C: An example of
clusters of adenocarcinoma cells in a mucin pool with pinpoint
solution applied; D: The same specimen as C after removal of the
tissue (4X).
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challenges to obtain adequate genetic material, irrespect-
ive of the tissue fragment size, include contamination of
tumor cells with surrounding necrosis, mucin pools, in-
flammatory cells, and other non-neoplastic cells. Laser
capture microdissection (LCM) [12,13] is an alternative;
but it requires special equipment and special training for
the medical technologists. It is also cost and space pro-
hibitive for many laboratories to invest in an LCM system.
Another obstacle during specimen processing in the
molecular diagnostic laboratory is accurate microdissec-
tion of marked tumor cell clusters from unstained slides.
Tumor cells present in the H&E reference slide may be
decreased or absent in the deeper unstained sections
leading to a falsely negative result. Accurate morpho-
logical visualization is essential in microdissection of small
biopsies [14]. Several groups have explored the possibility
of using histochemically stained slides for DNA extraction
and have reported adverse consequences of the staining
on DNA amplification [14-18]. Recently, Morikawa et al
[19] extensively studied the effects of H&E staining on
DNA testing and showed that neither the DNA yield
nor molecular oncologic test results were affected by
the stains.
The Pinpoint Slide DNA Isolation System (Zymo Re-
search Corp, Irvine, CA) is a matrix capture method which
allows lifting of tissue from the slides with ease and mini-
mizes the potential for tissue loss and contamination from
flaking of tissue during scraping of the slides (http://www.
zymoresearch.com/dna-purification/genomic-dna/solid-
ffpe-tissue-dna/pinpoint-slide-dna-isolation-system).
In this study, we compared our standard procedure of
manually microdissecting tissue from unstained FFPE
tissue on glass slides with a new method using the appli-
cation of Pinpoint solution (Zymo Research Corp) on
non-coversliped H&E stained slides. We also optimized
the DNA column purification steps by comparing the
column that came with the Pinpoint Slide Solution kit
(Zymo Research Corp) and the QIAamp DNA FFPE Tis-
sue kit (Qiagen, Valencia, CA).
Results
Comparison of tissue harvest and DNA extraction methods
To evaluate different tissue harvesting and DNA extrac-
tion methods, the specimens were divided into three
groups. The first group used the standard method in the
laboratory (U-SQ), in which unstained FFPE tissue was
scraped with a razor blade followed by extraction with
the QIAamp kit. The second and third groups employed
deparaffinization and H&E staining of the slides followed
by tissue harvest using the Pinpoint reagent. The speci-
men was then divided into two parts for extraction of
gDNA, one half with the Qiagen kit (Pinpoint harvest
with QIAamp column extraction, H-PQ) and the otherhalf with the Zymo kit (Pinpoint harvest with Zymo col-
umn extraction, H-PZ) as described above. The tissue
harvested for each test group was taken from different
levels of the same region on the slide to minimize vari-
ation in cellular density.
The Pinpoint reagent was effective at obtaining the tis-
sue from the slide. Figure 1A and B showed pre- and
post-harvest of a 1 mm2 nest of adenocarcinoma cells
from a Pinpoint-treated section. Figure 1C was an ex-
ample of clusters of adenocarcinoma cells in a mucin
pool with Pinpoint solution applied; and Figure 1D was
the same specimen as 1C after removal of the tissue.
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methods were compared via NanoDrop spectrophotom-
eter. The DNA yield on average from the Pinpoint
matrix capture with Qiagen column purification (H-PQ;
505.0 ng/mm2) was not statistically different from that
of the standard protocol (U-SQ, 555.0 ng/mm2) (Table 1).
A paired student’s t-test showed a p value of .31 which
provided evidence that the use of H&E staining and the
Pinpoint matrix capture did not significantly decrease
the yield of gDNA relative to the standard method. Sub-
sequently, we compared the performance of the two
DNA extraction columns using the H&E stained slides
and Pinpoint matrix captured tissues. The yield from the
Pinpoint harvest with QIAamp extraction column (H-
PQ; 505.5 ng/ mm2) was 4.6-fold higher than that of the
Zymo column (H-PZ; 109 ng/mm2) and the difference was
statistically significant (paired student’s t-test, p = .0005)
(Table 1). DNA quality assessed by the NanoDrop spectro-
photometer (A260/A280 ratio) demonstrated similar purity
between the two different methods (Table 1). Longer pro-
teinase K digestion (24-hour versus 4-hour) had no signifi-
cant effect on the DNA yield (student’s t-test on the means
of the DNA yield, p = 1.0). Based on the findings, H and E
stain with Pinpoint matrix capture and Qiagen column
purification (H-PQ) is the optimal method for tissue har-
vesting and DNA extraction.
We routinely cut 10 sections and the number of squares
(1 mm2 in size) was recorded and the DNA yield was
expressed as ng per mm2. Using the optimized protocol
(H-PQ), we also evaluated DNA yield from a 1 mm2
square from a single section. When the percentage of
cells in the area was close to 100%, the average DNA
yield was 430 ng/mm2.Assessment of DNA amplification and mutation detection
Molecular oncology assays have varying limits of detec-
tion and sensitivity to contaminating substances. The
Morikawa group [19] demonstrated that DNA obtained
from H&E stained tissue did not interfere with multiple








The samples were divided into three test groups: U-SQ: unstained slides were
scraped using a razor blade and gDNA was isolated by the Qiagen FFPE
column; H-PQ: Pinpoint solution was applied to H&E stained slides, followed
by extraction using the Qiagen column or Zymo column (H-PZ). See Methods
for details. *Statistically significant lower yield (p = .0005).amplify DNA obtained from all three methods for micro-
satellite instability allelic discrimination and variant detec-
tion using the more sensitive primer extension assay and
the less sensitive Sanger cycle sequencing. Although these
methods are not quantitative, they do provide a relative
assessment of mutation sequence representation within
the sample.
DNAs obtained from the H&E stained slides followed
by the Pinpoint matrix capture and QIAamp column
purification were used to perform various molecular on-
cology assays. Multiplex primer extension assays were
performed to detect the BRAF c.1799 T > A (p.V600E)
mutation in melanomas (n = 7), colorectal carcinomas
(n = 2), papillary thyroid carcinoma (n = 1) and a case of
Langerhans histiocytosis. Mutations in KRAS codons 12,
13 and 61 were tested similarly (n = 19) (representative
specimen size and microdissection shown in Figure 1A
and B). Figure 2 showed a BRAF c.1799 T > A, p.V600E
mutation in a case of malignant melanoma. The mutant
peak (green peak) was about 45% of the wild-type peak,
which was similar to the result using DNA extracted by
the previous U-SQ method (data not shown). Figure 3
showed a KRAS c.34G > T, p.G12D mutation detected in
a metastatic colon cancer by primer extension assay using
DNA extracted by the new method (H-PQ) (Figure 3A)
and the previous method using unstained slides (U-SQ)
(Figure 3B).
Sanger cycle sequencing, which was the least sensitive
assay, was performed on 23 cases of lung adenocarcinomas.
The electrophoretograms in Figure 4 showed successful de-
tection of a 15-bp deletion in exon 19 (c.2236_2250del15,
p.Glu764_Ala750del) (Figure 4A) and a heterozygous silent
mutation in exon 20 (c.2361G >A, p.Q787Q) (Figure 4B).
As a proof of concept, MSI testing was performed on
a mucinous adenocarcinoma of the colon using the five-
marker panel (D2S123, D5S346, D17S 250, BAT25 and
BAT26) recommended by the National Cancer Institute.
The amplification products were assessed by capillary
electrophoresis (Figure 5). Comparable ratio of tumor
and normal peak height was observed with DNA ob-
tained by the new method (H-PQ) and the standard
method (U-SQ).
Discussion
FFPE tissue is the most commonly used source for mo-
lecular oncology tests [20]. Obtaining gDNA of sufficient
quality and quantity from FFPE tissue is a critical step in
ensuring reliable test results. This process involves
selecting the right tissue block, marking area(s) with the
highest tumor content and least contaminating materials
by a pathologist, and microdissection of the marked area
to enrich tumor content. There are multiple methods
available for gDNA extraction from FFPE tissues from
the traditional phenol-chloroform extraction [21-23] to
Figure 2 Primer extension assay for BRAF V600 mutation
analysis. The primer extension assay was performed on a specimen
that was shown to be positive for BRAF V600E mutation previously.
A c.1799 T > A, p.V600E mutation was successfully identified using
DNA extracted by the new method (Pinpoint solution was applied
to H&E stained slides, followed by extraction using the Qiagen
column, H-PQ). Red peak is the wild-type (nucleotide T) and green
peak indicated by the arrow is the mutant peak (nucleotide A).
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matrix [24-26]. Extraction of DNA from cellular tumors
with a solid growth pattern and little contaminating, non-
neoplastic tissue is relatively easy, as with gastrointestinalstromal tumors for identification of the KIT mutations. In
contrast, increasing numbers of tests are requested on
small biopsies which usually contain small nests of tumor
cells surrounded by non-tumor tissue creating a challenge
in obtaining adequate material. Identifying small areas
with tumor on unstained slides adds a layer of uncertainty
to the process.
Traditionally, most clinical laboratories use unstained
slides for DNA extraction and H&E stained slides only as
a reference. Morikawa’s group [19] improved the specimen
processing significantly by assessing the DNA quality and
assay performance of over 1000 H&E stained FFPE cases.
They showed that H&E stain had no effect on DNA ex-
traction. Based on their findings, in this study, we H&E
stained all the sections in the experimental groups. Each
section was examined by a pathologist and the areas with
tumor were circled on the back of the slides.
H&E stain allowed us to visualize the presence of tumor
cells on the slides during microdissection and reduce the
risk of false negative results. In a significant portion of the
cases, changes in tumor location and/or content were ob-
served (data not shown). In fact, some laboratories rou-
tinely stain the first and last sections of the tissue block in
order to minimize the false negative result. A drawback
for H&E stained sections is the tissue tends to flake off in
a dry powder while scraping. We therefore explored the
Pinpoint matrix capture solution (Zymo Research Corp)
for tissue harvest. The Pinpoint solution kept the cells to-
gether and allowed easy harvesting of minute tumor clus-
ters surrounded by non-neoplastic cells. It also minimized
potential contamination from tissue flakes in the work
area and loss of valuable tumor tissue.
The advance in high throughput technology such as
massively parallel sequencing [27-29] and the multi-
plexed genotyping method developed by Sequenom
(Sequenom Inc., San Diego, CA) [30,31] allows multiple
tests to be run at the same time with much less input
DNA. DNAs obtained by our new extraction method
worked well on the Ion Torrent AmpliSeq™ Cancer Hot-
spot Panel v2 (Life Technologies, Carlsbad, CA, data not
shown). Both NGS and the Sequenom platforms require
extensive test validation, strong bioinformatic support
and a reasonable test volume to bring them on board. In
small and medium sized clinical laboratories, Sanger se-
quencing and other low-throughput methods, which re-
quires more input DNA, are still and will be used for
oncology testing for a period of time. Our newly devel-
oped DNA extraction method allows us to obtain suffi-
cient DNA from minute foci of tumor (1-2 mm2).
Test performance with DNA isolated with the new
method was evaluated. Equivalent performance was ob-
served on all assays tested in comparison with using DNA
extracted by the standard method in the laboratory. Aber-














Figure 3 Primer extension assay for KRAS codons 12, 13, and 61 mutation analysis. DNA obtained from the new extraction method
(Pinpoint solution was applied to H&E stained slides, followed by extraction using the Qiagen column, H-PQ) was used in a multiplex primer
extension assay for detecting codons 12, 13, and 61 mutations (representative specimen size and microdissection shown in Figure 1A and B).
A. KRAS c.34G > T, p.G12D mutation was identified in a case of colon cancer using DNA extracted by the new method (H-PQ). B. DNA extracted
using the traditional extraction method (U-SQ) from the same specimen. Black peak is the wild type (nucleotide C) and the green mutant peak
(nucleotide T) is indicated by the arrows. An antisense probe was used in this test.
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tension assay, deletion and SNP in the EGFR gene from
lung adenocarcinomas by Sanger cycle sequencing,
G12D mutation in the KRAS gene from a metastatic
colon cancer using primer extension assay, and a multi-
plex PCR-based assay for microsatellite instability test
from a colon biopsy with clusters of signet ring cells in a
pool of mucin. The new method also yield good quality
DNA based on the finding that the test performance
was not affected.
An additional advantage of the new method is the re-
duced cost. The Leica machine used in our histology la-
boratory can automatically deparaffinize the slides without
changing the frequency of reagent replenishment. Thesavings came from eliminating the need for buying xy-
lene, ethanol, centrifuge tubes, and 1 ml pipet tips
which were all needed for the manual deparaffinization
procedure.Conclusion
We developed a simple and cost-effective method for
gDNA extraction from minute FFPE tissue. The com-
bination of H&E stain with matrix capture method and
the QIAamp column yielded an equivalent quantity of
DNA as our standard extraction method without com-
promising the qualitative test results. This method also
reduced the cost, blended into our work flow nicely and
Figure 4 Sanger cycle sequencing for EGFR mutation analysis. Sanger cycle sequencing for EGFR exons 18-21 was performed on DNA
obtained with the new extraction method (H-PQ, see Methods for details). A: Electrophoretograms showing a 15-bp deletion in exon 19
(c.2236_ 2250del15, p.Glu764_Ala750del) of the EGFR gene. Arrows marked the starting and ending positions of the deletion. B: A heterozygous
silent mutation in exon 20 (c.2361G > A, p.Q787Q).
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method for obtaining high quality and quantity DNA
from small, challenging specimens for molecular onco-
logic testing in the clinical laboratories.Methods
This is a retrospective study based on data from clinical test
development. The study was approved by the Institutional
Review Board of University of Iowa.Case selection
Cases included in this study were selected from de-
identified FFPE tissues that have been previously tested
in the Molecular Pathology Laboratory at our institution
since October, 2012. Special attention was paid to select
cases that represented the spectrum of tissue and assays
used for oncology testing. Among them, there were 19
cases of colorectal carcinomas for KRAS testing, 23
cases of lung adenocarcinomas for EGFR exons 18-21




D5S346 BAT26 D2S123 BAT25 D17S250
Figure 5 Microsatellite instability testing (MSI) for colorectal mucinous adenocarcinoma. MSI testing was performed using the 5-marker
panel recommended by the National Cancer Institute. The laboratory routinely used 500 ng gDNA for this test. Similar peak height was obtained
with 10-fold less DNA isolated by the newly developed extraction method (Figure 5). A: normal tissue; B: using tumor DNA extracted by the
traditional method (U-SQ); C: using tumor DNA extracted by the new method (H-PQ).
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cinoma and 1 Langerhans histiocytosis), and 1 case of
colorectal carcinoma with matched normal tissue for
microsatellite instability analysis.Laboratory standard protocol for isolation of genomic
DNA from FFPE tissue
All cases were reviewed by a pathologist and the optimal
block was selected for molecular testing. One H&E stained
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ness) were cut. Areas of interest were circled on the H&E
slide by a pathologist and corresponding areas from the
unstained slides were manually microdissected using a
razor blade. The paraffin flakes were placed in a 1.5 ml
microcentrifuge tube, deparaffinized with 1200 μL of xy-
lene, vortexed, and centrifuged at 16,000 g × 5 min. The
tissue pellet was washed with 95% ethanol twice before
proceeding with the extraction. Genomic DNA was iso-
lated from the microdissected FFPE sections using the
QIAamp DNA FFPE Tissue kit (Qiagen) which will be
referred to as U-SQ (Unstained slides, Scraped harvest
method, Qiagen extraction column). The deparaffinized
tissue was resuspended in 180 μl of Buffer ATL,
followed by 50 μl of Proteinase K (600 mAU/ML) diges-
tion at 56°C overnight till the specimen was completely
lysed. The lysate was incubated at 90°C for one hour to
partially reverse the formaldehyde modification of nu-
cleic acids. After briefly centrifugation of the tube to re-
move drops from the inside of the lid, 200 μl of Buffer
AL was added, and the mixture was vortexed for 15 sec-
onds. 200 μl of ethanol (96-100%) was added and mixed
by vertexing for 15 seconds. The mixture was incubated
for 5 min at room temperature, briefly centrifuged and
the entire lysate was transferred to the QIAamp MinE-
lute column. DNA was extracted according to the man-
ufacturer’s instruction included in the kit.
Matrix-capture protocol
One H&E slide with cover-slip and 10 unstained sections
were obtained as described above. The unstained slides
were deparaffinized and H&E stained in our histology la-
boratory using a standard protocol on the Leica ST5020.
This automated instrument submerges the slides through
three changes of xylene followed by a gradient of washes
with 100% ethanol, 95% ethanol, 70% ethanol, and water.
After deparaffinization, the slides were processed through
the H&E staining wells. No coverslip was placed. The
underside of the uncover-slipped slides was marked by a
pathologist and the pinpoint matrix capture solution
(Zymo Research Corp) was applied to the slide and
allowed to air dry. Tissue bound to the dried solution was
removed from the slide using a razor blade (Figure 1).
After proteinase K digestion at 55°C for 24 hours, the
sample was divided into two aliquots for genomic DNA
isolation either by the QIAamp DNA FFPE Tissue kit
(Qiagen) as described earlier or the Pinpoint Slide DNA
Isolation kit (Zymo Research Corp). Genomic DNA ex-
traction using the Zymo kit was performed as follows:
50 μl of Extraction Buffer and 5 μl Proteinase K were
added to the tube of recovered tissue. The tube was incu-
bated at 55°C overnight, followed by heat-inactivation at
98°C for 10 minutes. The tube was placed immediately on
ice, vortexed vigorously for 15 seconds and centrifuged at16,000 g × 5 min. The supernatant was transferred to a
clean tube. The DNA concentration was measured by
the NanoDrop spectrophotometer (NanoDrop, Westlake
Village, CA) and the quality of gDNA was assessed by the
ratio of absorbance at 260 nm and 280 nm. These two
methods were designated as H-PZ for H&E stained slides,
Pinpoint matrix capture and Zymo Slide DNA Isolation
kit and H-PQ for H&E stained slides, Pinpoint matrix
capture with the Qiagen QIAamp DNA FFPE column
purification.
Comparison of tissue harvest and DNA extraction
methods
The specimens were divided into three groups. The first
group used the standard method in the laboratory (U-SQ).
In this method, unstained FFPE tissue was scraped with a
razor blade followed by extraction with the QIAamp kit as
described above. The second and third groups employed
deparaffinization and H&E staining of the slides followed
by tissue harvest using the Pinpoint reagent. The speci-
men was then divided into two parts for extraction of
gDNA, one half with the Qiagen kit (Pinpoint harvest with
QIAamp column extraction, H-PQ) and the other half
with the Zymo kit (Pinpoint harvest with Zymo column
extraction, H-PZ) as described above. The tissue harvested
for each test group was taken from different levels of the
same region on the slide to minimize variation in cellular
density.
Molecular tests performed
BRAF codon V600 mutation analysis by primer extension
assay
BRAF exon 15 was PCR amplified using primers 5′-GA
TCCCTTTACTTACTACACCTCAG-3′ and 5′-GATCG-
TAACTCAGCAGCATCTC-3′. Mutations in codon V600
were examined by single nucleotide primer extension
assay using the Snapshot Multiplex kit (Applied Biosys-
tems, Foster City, CA). The V600 codon was interro-
gated with a sense probe consisting of deoxy-thymidine
monophosphate homopolymers of varied sizes for dis-
crimination of different mutation products [32] (See ref-
erence [32] for probe sequences). After amplification,
the product was subjected to probe annealing and
addition of a single, fluorescently labeled dideoxynu-
cleotide. The primer extension products were analyzed
by capillary electrophoresis.
KRAS codon 12, 13, and 61 mutation analysis by primer
extension assay
This assay was performed with a similar procedure to that
described for the BRAF V600 primer extension assay
above. In this assay, exons 2 and 3 of the KRAS gene
were amplified using specific primers in a multiplex
reaction (see reference 32 for primer sequences). The
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lengths of deoxythymidine monophosphate homopolymers
ranging from 30 to 76 bases to allow for discrimination of
the products by size. The sense probes were designed to
end one base 5′ of the following positions: c.35, c.38, and
c.182. The antisense probes were designed to end one base
5′ of the following positions: c.34, c.37, c.57, c.181, and
c.183. These probes allowed for the detection of common
variants present in codons 12, 13, and 61 of the KRAS
gene.
EGFR mutation analysis by Sanger sequencing
Exons 18-21 of the EGFR gene were PCR amplified using
primers designed to produce one amplicon per exon. Pri-
mer sequences were: 5′-TCTGGCACTGCTTTCCAGC-
3′ and 5′-TCCCAAACACTCAGTGAAACAAA-3′ for
exon 18; 5′-ACCCAG ATC ACTGGGCAGC-3′ and 5′-
AGCAGCTGCCAGACATGAG-3′ for exon 19; 5′-CTG
GCCACCATGCGAAGCC-3′ and 5′-ATCCTGGCTCCT
TATCTCC-3′ for exon 20; and 5′-CCCATGATGATC
TGTCCCT-3′ and 5′-TGGTCCCTGGTGTCAGGAA-3′
for exon 21. 25 to 150 ng of gDNA was used as the
starting material in each amplification reaction. The
PCR thermocycling conditions were as follows: 94°C for
2 minutes, followed by 30 cycles of 94°C for 15 seconds,
58°C for 30 seconds, and 72°C for 30 seconds. The amp-
lification products were purified using the Qiagen QIA-
quick PCR purification kit (Qiagen). Cycle sequencing
was performed using the ABI Big Dye Terminator Mix,
version 3.1 and the products were separated by capillary
electrophoresis on an ABI 3130 Genetic Analyzer (Ap-
plied Biosystems).
Microsatellite instability testing by PCR followed by
capillary electrophoresis
The National Cancer Institute (NCI) recommended five-
marker panel (two mononucleotide markers, BAT25 and
BAT26 and three dinucleotide markers, D2S123, D5S346
and D17S250) were used for microsatellite instability test-
ing in two multiplexed reactions with fluorescently labeled
primers. Genomic DNA extracted from tumor and paired
normal tissue from the same patient was used. The ampli-
cons were then analyzed using capillary electrophoresis.
Comparison of 4-hour versus overnight proteinase K
digestion
Three samples with uniform cellularity were selected.
Ten slides were prepared by deparaffinization and H&E
staining without placement of coverslips. Areas with the
greatest cellular uniformity were marked by a pathologist
using a 2 mm × 2 mm template. The pinpoint reagent
was applied and the dried matrix was removed as de-
scribed above. The matrix pellet was digested with pro-
teinase K at 55°C for 4 hours and then divided into twoaliquots: one was extracted immediately using the
QIAamp FFPE kit (Qiagen); the other one was subjected
to continued proteinase K digestion overnight and DNA
was extracted using the same column type the next day.
Optical densitometry was performed after extraction
and the mean concentration values were compared
statistically.
Statistical analysis
Statistical analysis was performed using the paired two-
sample student’s t-test. A significant difference is defined
as p value less than .05.
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